Mark S. Eberhardt
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes Management and Education
- Nephrology top 0.5%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 14
- Diabetes Management and Research 7
- Genetics 13
- Diabetes and associated disorders 13
- Co-authors
- Catherine C. Cowie (10 shared papers)Katherine M. Flegal (8 shared papers)Danita D. Byrd-Holt (4 shared papers)Maureen I Harris (5 shared papers)Sharon Saydah (10 shared papers)Randie R. Little (2 shared papers)Hsiao-Mei Wiedmeyer (2 shared papers)David E. Goldstein (2 shared papers)
- Journals
- Diabetes Care (13 papers)American Journal of Kidney Diseases (5 papers)Diabetes (3 papers)Diabetes Research and Clinical Practice (2 papers)American Journal of Epidemiology (2 papers)
- Partner nations
- United StatesThailandAustralia
In The Last Decade
Mark S. Eberhardt
70 papers receiving 10.8k citations
Mark S. Eberhardt's Hit Papers
Peers
Comparison fields: 5 of 175
- Endocrinology, Diabetes and Metabolism 3.7k
- Nephrology 971
- Pharmacy 339
- Epidemiology 1.4k
- Physiology 1.0k
Countries citing papers authored by Mark S. Eberhardt
This map shows the geographic impact of Mark S. Eberhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Eberhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Eberhardt more than expected).
Fields of papers citing papers by Mark S. Eberhardt
This network shows the impact of papers produced by Mark S. Eberhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Eberhardt. The network helps show where Mark S. Eberhardt may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark S. Eberhardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 Hit paper breakdown → | 1998 | 2241 |
| 2 | Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. Population Hit paper breakdown → | 2006 | 1037 |
| 3 | Full Accounting of Diabetes and Pre-Diabetes in the U.S. Population in 1988–1994 and 2005–2006 Hit paper breakdown → | 2008 | 946 |
| 4 | Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994 Hit paper breakdown → | 2013 | 659 |
| 5 | Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Hit paper breakdown → | 1999 | 556 |
| 6 | The Importance of Place of Residence: Examining Health in Rural and Nonrural Areas Hit paper breakdown → | 2004 | 507 |
| 7 | Prevalence of Lower-Extremity Disease in the U.S. Adult Population ≥40 Years of Age With and Without Diabetes Hit paper breakdown → | 2004 | 487 |
| 8 | Trends in Prevalence of Chronic Kidney Disease in the United States Hit paper breakdown → | 2016 | 455 |
| 9 | 2002 | 352 | |
| 10 | 2000 | 319 | |
| 11 | 2010 | 306 | |
| 12 | 2003 | 302 | |
| 13 | Health, United States, 2001; with Urban and rural health chartbook | 2001 | 302 |
| 14 | 2002 | 239 | |
| 15 | 2006 | 208 | |
| 16 | 1997 | 201 | |
| 17 | 2001 | 187 | |
| 18 | 2009 | 177 | |
| 19 | 2002 | 143 | |
| 20 | 2010 | 129 |
About Mark S. Eberhardt
Mark S. Eberhardt is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Surgery, Nephrology and General Health Professions, having authored 70 papers that have together received 11.4k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers), Diabetes and associated disorders (13 papers), Chronic Kidney Disease and Diabetes (8 papers), Diabetes Management and Research (7 papers), Pancreatic function and diabetes (6 papers), Gestational Diabetes Research and Management (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Healthcare Policy and Management (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.7k citations), Nephrology (971 citations), Pharmacy (339 citations), Epidemiology (1.4k citations) and Physiology (1.0k citations). Mark S. Eberhardt has collaborated with scholars based in United States, Thailand and Australia. Frequent co-authors include Catherine C. Cowie, Katherine M. Flegal, Danita D. Byrd-Holt, Maureen I Harris, Sharon Saydah, Randie R. Little, Hsiao-Mei Wiedmeyer, David E. Goldstein, Elsie R. Pamuk and Linda S. Geiss. Their work appears in journals such as Diabetes Care, American Journal of Kidney Diseases, Diabetes, Diabetes Research and Clinical Practice and American Journal of Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.